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Exceptional Case
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Abstract
Hypertensive crises in children or adolescents are rare, but chronic kidney disease (CKD) is a major
risk factor for occurrence. Vesicoureteral reﬂux nephropathy is a common cause of pediatric renal
failure and is associated with hypertension. Aggressive blood pressure (BP) control has been shown
to delay progression of CKD and treatment is targeted for the 50th percentile for height when compared with a target below the 90th percentile for the general pediatric hypertensive patient. We
present a case of an adolescent presenting with seizures and renal failure due to a hypertensive
crisis. Hypertension was thought to be secondary to CKD as she had scarred echogenic kidneys due
to known reﬂux nephropathy. However, aggressive BP treatment improved kidney function which is
inconsistent with CKD from reﬂux nephropathy. Secondly, aggressive BP control caused transient
neurological symptoms. Further imaging identiﬁed moyamoya disease. We present this case to
highlight the consideration of moyamoya as a diagnosis in the setting of renal failure and hypertensive crisis.
Keywords: acute renal failure; hypertension; hypertensive emergency; moyamoya; reﬂux nephropathy; vesicoureteral reﬂux

Introduction
Severe hypertension in pediatric patients is thought to be
secondary and often related to renovascular disease. For
this reason, pediatric nephrologists have become the blood
pressure (BP) specialists for children with hypertension. In
children, neurological causes of hypertension are often
related to increased intracranial pressure whereas cerebrovascular causes are rare. The neurological consequences
of hypertension are stroke, seizures and encephalopathy.
Therefore, it is often presumed that renovascular disease
leads to hypertension which leads to neurological disease.
We report a case of neurological disease, moyamoya, causing hypertension, leading to partially reversible kidney
failure. We present this case to highlight the consideration of
moyamoya as a cause of hypertensive renal failure.

Case presentation
Emergent management
A 16-year-old adolescent female awoke with severe headache early in the morning. Paracetamol (acetaminophen)

was taken, but offered no relief. Over the next 4 h the
headache was unremitting and she developed nausea
with emesis. She had sudden incoherence of speech with
bowel and bladder incontinence. She was taken to a local
hospital and was noted to have a focal seizure with left
facial and hand twitching which stopped with intravenous
lorazepam. A computed tomography (CT) scan of the
head without contrast was normal. BP was 200/140
mmHg. A single dose of hydralazine 10 mg was administered intravenously. After stabilization she was transferred
by air to a tertiary care center. Upon arrival she was admitted to the pediatric intensive care unit. BP remained
elevated at 228/123 mmHg. She was encephalopathic
with left hemiparesis. She began vomiting. She was intubated for airway protection. She was immediately placed
on an intravenous infusion of nicardipine at 0.5 µg/kg/min
without a bolus dose. An intra-arterial BP catheter was
placed to allow titration of the nicardipine infusion. Chest
X-ray showed bilateral perihilar inﬁltrates consistent with
pulmonary edema. Continuous electroencephalogram
did not reveal seizures, but right hemispheric slowing.
The target BP for the ﬁrst 8 h was to maintain above
171/105 mmHg (<25% reduction in maximum BP for both
systolic and diastolic) to prevent a precipitous drop and
avoid inducing irreversible neurological damage.
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were negative. Complement levels: C3 and C4 were normal.
ESR was elevated at 83 mm/h. Repeat MRI/MRA without
contrast showed near complete resolution of previously
seen T2/FLAIR hyperintensities although there was no ﬂow
in the right M1 and A1 segment. Even with this persistent
MRA abnormality, her rapid return to normal without
neurological deﬁcit and near-complete resolution of FLAIR
signal abnormalities was thought to be most consistent
with PRES. Furthermore, kidney function remained compromised (creatinine peaked at 645.3 µmol/L [7.3 mg/dL];
eGFR 10 mL/min/1.73 m2), and therefore we were reluctant
to proceed with a conventional angiogram as it was likely
to result in the need for dialysis due to contrast nephropathy. She was discharged home on four antihypertensive
agents and furosemide for a target BP at the 50th percentile for height with close follow up.
Long-term management

Over the next 96 h intravenous nicardipine (dose range of
2–10 µg/kg/min) and furosemide (0.1 mg/kg/h) were
infused in an attempt to normalize BP to less than the
90th percentile for height (126/81 mmHg) (Figure 3). Her
mental and neurological status returned to baseline
without appreciable deﬁcits and she was extubated. Over
a 2-week hospital course she was transitioned to oral antihypertensive agents including amlodipine 5 mg twice
daily, atenolol 50 mg daily, clonidine 0.1 mg twice daily, lisinopril 2.5 mg twice daily and furosemide 40 mg twice
daily (Figure 3). Evaluation for autoimmune disease and
vasculitis included ANA, ANCA, anti-GBM antibodies—all

Over a 6-month period she remained on three or four antihypertensive medications which were adjusted to target a
BP below 112/66 mmHg (50th percentile for height). In
addition, she was started on epoetin alpha 2000 units2
weekly, calcitriol 0.25 µg daily, sodium bicarbonate 1300
mg twice daily and calcium acetate 667 mg tab with food
for chronic kidney disease (CKD) management. Kidney
function improved (creatinine declined to 265.2 µmol/L
(3 mg/dL); eGFR 24 mL/min/1.73 m2), anemia was treated
to a target of <6.8 mmol/L (11 g/dL) (she required no
transfusions), and serum phosphorous was consistently
less than 1.94 mmol/L (6 mg/dL). However, she had intermittent periods of altered mental status and developed
chronic headaches. Each episode was in the context of a
presumed vasovagal/pre-syncopal episode.
One episode occurred during a hot shower. Upon
getting out of the shower, she developed vertigo and
ataxia and fell to the ﬂoor. She was evaluated in an emergency room (ER). She had a normal examination. BP in the
ER was 105/60 mmHg. She was given ﬂuids and had good
urine output. Her symptoms were attributed to aggressive
BP control. Clonidine was discontinued and furosemide
was decreased by half the dose to 20 mg twice a day.
A second episode was associated with severe headache
and occurred at school. When getting up from her desk

Figure 1. (A) MRI without contrast enhancement FLAIR signal showing
hyperintensity in the right parietal lobe (white arrow), head of caudate
nucleus (asterisk) and adjacent white matter. (B) Sequential image of
series showing hyperintensity in the temporal lobe (short arrow), putamen
(double asterisks) and right parietal lobe (long arrow). MRI, magnetic
resonance imaging; FLAIR, ﬂuid attenuated inversion recovery.

Figure 2. MRA without contrast enhancement using time-of-ﬂight technique
shows diminished ﬂow in right MCA M1 (white arrow) and bilateral ACA A1
segments (black arrows). MRA, magnetic resonance angiography; MCA,
middle cerebral artery; ACA, anterior cerebral artery.

Initial hospital course
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Past medical history was signiﬁcant for grade III vesicoureteral reﬂux (VUR) diagnosed at age 12 after CT scan
for appendicitis identiﬁed acute appendicitis and scarring
of the upper poles of both kidneys. She had bilateral ureteral implantation at the age of 13. She had been seen in an
outpatient pediatric nephrology clinic 9 months prior to this
presentation. Systolic BP at that time was 120 mmHg; Hgb
75.1 mmol/L (12.1 g/dL); serum creatinine was 79.6 µmol/L
(0.9 mg/dL) [eGFR 78 mL/min/1.73 m2]; urinalysis with 3+
protein, without hematuria.
Current laboratory studies showed a serum creatinine of
415.5 µmol/L (4.7 mg/dL). Urinalysis showed 3+ protein and
3+ blood without red blood cells or casts on microscopy.
Drug screen was negative except for benzodiazepines.
White blood cell count was 14.4K/mm3 with 94% neutrophils; Hgb 67.6 mmol/L (10.9 g/dL). Magnetic resonance
imaging (MRI)/magnetic resonance angiography (MRA)
without contrast showed abnormal T2/FLAIR signal in the
cortical and subcortical regions of the right parietal temporal lobe and basal ganglia consistent with either subacute
infarction in the right MCA territory without diffusion restriction or an atypical presentation of posterior reversible
encephalopathy syndrome (PRES) (Figure 1A and B). MRA revealed diminished ﬂow in the right M1 segment (Figure 2).
Renal ultrasound showed small echogenic kidneys bilaterally (right 6.9 cm; left 7.8 cm) with cortical scarring and loss
of corticomedullary differentiation. Ultrasound was felt to
be consistent with and supported VUR nephropathy as the
cause of the hypertensive renal failure.
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Figure 4. (A) CNS angiogram shows an early time point of the study highlighting a tightly stenosed terminal right internal carotid artery (white arrow)
with collateral lenticulostriate vessels (black arrow). (B) Later time point of study with asterisk indicating ‘puff of smoke’ appearance because of the
collateral ﬂow through the numerous lenticulostriate vessels.

she became ‘dizzy’, began seeing ‘spots’, and was nauseated. The school nurse recorded her BP at 110/63
mmHg. Neurological examination in the ER was normal
with a BP of 117/72 mmHg. The headache was characterized as band like, associated with photo- and phonophobia.
She was diagnosed with a migraine headache. Atenolol
was changed to extended release metoprolol 25 mg and
amitriptyline 10 mg nightly was prescribed.
A few weeks later the patient noticed a subtle numbness in her left hand and leg. She preferred receiving the
epoetin alpha injection in her left thigh because she
noticed that it hurt less. Two days prior to readmission,
her father stepped on her foot and it did not hurt! On the

day of readmission, she developed facial numbness ‘I felt
like I was at the dentist and somebody gave me novocain’.
Her left arm felt heavy and clumsy. She presented to her
primary medical doctor who referred her to the ER. On
physical examination, BP was 126/75 mmHg. She had new
left-sided arm weakness with numbness to light touch as
well as decreased sensation to pin and temperature on
the left side of the face. Although in the past we had been
reluctant to use iodinated contrast, in the setting of a new
focal deﬁcit, a conventional angiogram of the central
nervous system (CNS) with iodinated contrast was performed. It was consistent with moyamoya disease
(Figure 4).
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Figure 3. Graphical representation of patient’s blood pressure, target ranges and medications prescribed during initial hospitalization.
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Case discussion
Hypertensive crises are caused by severe hypertension
and can be divided into two categories: emergent or
urgent. Hypertensive emergencies are occurring when
there is evidence of evolving injury to the cardiovascular
system (heart failure, pulmonary edema), kidneys (renal
failure) or CNS (seizures, altered mental status, transient
ischemia, stroke) due to endothelial damage from shear
stress. Hypertensive urgency is deﬁned as the presence of
severe hypertension with no acute end-organ damage.
Pediatric hypertensive emergencies are rare. This is in
stark contrast to adult medicine where it is reported that
of the 27% of the adult population affected by hypertension, 1% of these patients will at some point develop a hypertensive crisis [1]. Furthermore, 25% of all adult patient
visits to the ER are related to hypertension and in onethird of these cases a hypertensive emergency is occurring
[2]. In pediatrics, the causes of hypertension and hypertensive crisis vary by age although after the age of
6 years, primary hypertension is the most common cause.
However, severe pediatric hypertension, which is commonly deﬁned as a level 20 mmHg above the 95th percentile for height is most often secondary [3]. Renal disease is
the most common cause of secondary hypertension and
hypertensive crises [4]. In our patient, it was presumed
that the presentation of hypertensive encephalopathy
was due to renal failure from reﬂux nephropathy.
Reﬂux nephropathy is a recognized cause of both renal
failure and hypertensive renal crisis in adolescent patients
[3]. Although our patient’s renal failure was precipitous,
hypertension is a major risk for progression of CKD and we
believed that the hypertensive crisis further accelerated
the progression. A kidney biopsy was not performed
because it was felt that the renal ultrasound was consistent with chronic VUR and therefore was unlikely to change
management; while at the same time there would be a
high likelihood of bleeding complications due to the uncontrolled hypertension and renal failure during biopsy.
Her neurological status returned to baseline without any
focal deﬁcits. She was discharged home with a diagnosis
of PRES and CKD. She was placed on an intensive BP
regime with twice daily monitoring and target BPs at or
below the 50th percentile based upon favorable outcomes
from the Effect of Strict Blood Pressure control and ACE
inhibition on the Progression of CRF in Pediatric patients
(ESCAPE) trial group [5]. We originally deferred cerebral
angiogram because of the renal failure.

In hindsight, it was appreciated that the episodes of
altered mental status were ischemic in nature and not vasovagal. The aggressive BP control in an attempt to slow
progression of CKD and avoid dialysis actually induced
transient CNS ischemia—unmasking moyamoya. Moyamoya is an occlusive disease of the cerebral vasculature
involving the internal carotid arteries with the development of collateral circulation from the leptomeninges and
branches of the external carotid [6]. The collateral circulation has the appearance of a ‘puff of smoke’—the translation for the Japanese word ‘moyamoya’. Although
pediatric moyamoya has been associated with severe hypertension [7–10], we believe that this case is the ﬁrst to
present as a hypertensive emergency with renal failure
and highlights this disease for consideration in the differential diagnosis of hypertensive renal failure (Table 1).
There are two possible mechanisms of hypertension
related to moyamoya disease: (i) systemic compensation
due to cerebral hypoperfusion or (ii) ﬁbromuscular dysplasia of the renal arteries with resultant renovascular hypertension. The occlusive vasculopathy of moyamoya can be
systemic and affect the vasculature of a number of organ
systems. Renal artery stenosis (RAS) occurs in 7% of the
Japanese population with moyamoya [11]. However, children are disproportionately affected (a breakdown shows
that 45% were children) [8, 11, 12]. In a more heterogeneous population, 20% of children with moyamoya also
had RAS according to a study from Great Ormond Street
Hospital [8].
A renal angiogram was performed at the time of the
CNS study (Figure 5). No evidence of RAS was found,
although there was ‘pruning of the distal arteries consistent with chronic kidney disease’. Therefore, it seems that
in our patient the hypertension was due to compensation
from cerebral hypoperfusion. This is again unique as all
previous cases of renal failure associated with moyamoya
have documented RAS. We appreciate that the occlusive
vasculopathy of moyamoya can involve small arteries
and therefore cannot entirely ascribe the ﬁndings of the
angiogram to CKD with absolute certainty. Therefore, we
support that in the setting of hypertension and moyamoya disease, evaluation of the renal vasculature with
imaging and plasma renin levels should be performed and
a strong suspicion for RAS should be maintained [13].
Our patient underwent an indirect revascularization of
the CNS by an EDAS procedure. This technique involves

Table 1. Differential diagnosis of severe hypertension and renal
failure
Glomerulonephritis
Acute post-streptococcal glomerulonephritis
Lupus nephritis
Ig A nephropathy with nephritic presentation
Pauci-immune crescentic glomerulonephritis (see vasculitis below)
Membranoproliferative glomerulonephritis
Anti-glomerular basement membrane antibody disease
Vasculitis
Granulomatosis with polyangiitis
Microscopic polyangiitis
Churg-strauss
Polyarteritis nodosa
End-stage renal disease
VUR nephropathy, PUV/CAKUT, nephronophthisis
Hemolytic uremic syndrome
Scleroderma renal crisis
Moyamoya
VUR, vesicoureteral reﬂux; PUV, posterior urethral valves; CAKUT,
congenital anomalies of the kidney and urinary tract.
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Upon the diagnosis of moyamoya, aggressive BP control
for a target below the 50th percentile was recognized as
potentially detrimental and contributory to her neurological symptoms. She recovered left-sided strength within
24 h. The target BP was revised to maintain a goal between
the 50th and 95th percentile (she remained on lisinopril
10 mg twice daily, amlodipine 10 mg daily, metoprolol
ER 25 mg daily and furosemide 20 mg twice daily). Two
weeks after the angiogram identiﬁed moyamoya, she underwent a right-sided encephaloduroarteriosynangiosis
(EDAS) with pial synangiosis revascularization. BP medications were held 24 h prior to surgery. She was discharged
on post-operative day 6. Since the surgery BP targets remain
above the 50th percentile and the calcium-channel blocker
and beta-blocker have been discontinued. BP is controlled
on lisinopril 10 mg twice daily and furosemide 20 mg daily.
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placement of vascularized tissue supplied by the external
carotid artery (which is not typically affected by moyamoya) in direct contact with the brain. This then leads to
in-growth of new blood vessels ‘vascularizing’ the underlying ischemic area [6]. Surgical revascularization has
gained acceptance as a primary treatment for moyamoya.
The greatest risk for stroke after revascularization is within
the ﬁrst 30 days (reportedly 4% per hemisphere).
However, thereafter the probability of being stroke-free at
5 years is 96% [6, 14, 15]. Since surgery we have been able
to wean antihypertensive agents, a phenomenon which
has been previously described [16]. This further supports
that hypertension was not renovascularly but cerebrovascularly driven.
In conclusion, this case highlights that moyamoya must
be considered in the differential diagnosis of patients presenting with hypertensive emergency and renal failure.
Although CKD is a major risk factor of hypertensive emergencies with reports indicating that 79% of adult patients
have CKD stage 2 or greater [17], there are a number of
causes that must be considered (Table 1). We attributed
the hypertensive emergency to CKD causing acute kidney
injury and PRES. We were pleased as neurological status
and kidney function improved potentially inducing diagnostic inertia. However, the long-term management of
CKD with aggressive BP control induced transient ischemia
because of moyamoya. Recognition of moyamoya led to
surgical revascularization and has changed our medical
management to accept higher blood pressures up to the
90th percentile.
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Figure 5. Renal angiogram. Single renal arteries (white arrows) with no
ostial stenosis. Both renal arteries show distal pruning consistent with CKD.
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